Immix Biopharma, Inc.

8-K Other events Jul 20, 2026 8-K Shareholder vote results May 29, 2026 8-K Other events May 21, 2026 8-K Regulation FD disclosure; Other events May 21, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Regulation FD disclosure; Other events Mar 30, 2026 10-K/A Fiscal year ended 2025-12-31 Mar 27, 2026 8-K Entered a material agreement Mar 25, 2026 10-K Fiscal year ended 2025-12-31 Mar 25, 2026 8-K Entered a material agreement Dec 8, 2025 8-K Regulation FD disclosure; Other events Dec 8, 2025 8-K Other events Nov 26, 2025 10-Q Quarter ended 2025-09-30 Nov 7, 2025 8-K Entered a material agreement; Unregistered sale of equity; Director or officer change Sep 8, 2025 10-Q Quarter ended 2025-06-30 Aug 8, 2025 8-K Shareholder vote results Jun 23, 2025 8-K Entered a material agreement Jun 3, 2025 10-Q/A Quarter ended 2025-03-31 May 19, 2025 10-K/A Fiscal year ended 2024-12-31 May 19, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 10-K Fiscal year ended 2024-12-31 Mar 25, 2025 10-Q Quarter ended 2024-09-30 Nov 12, 2024 10-Q Quarter ended 2024-06-30 Aug 12, 2024 8-K Other events Jul 26, 2024 8-K Changed accountants Jul 22, 2024 8-K Director or officer change; Shareholder vote results Jun 14, 2024 8-K Unregistered sale of equity; Other events May 20, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 10-K Fiscal year ended 2023-12-31 Mar 29, 2024 8-K Entered a material agreement; Other events Feb 6, 2024 8-K Other events Feb 5, 2024 10-Q Quarter ended 2023-09-30 Nov 13, 2023 8-K Entered a material agreement; Unregistered sale of equity; Director or officer change Aug 22, 2023 10-Q Quarter ended 2023-06-30 Aug 11, 2023 8-K Entered a material agreement Jul 14, 2023 8-K Shareholder vote results Jun 8, 2023 10-Q Quarter ended 2023-03-31 May 12, 2023 10-K Fiscal year ended 2022-12-31 Mar 27, 2023 8-K Entered a material agreement Mar 22, 2023 8-K/A Regulation FD disclosure Mar 13, 2023